This second screening campaign aims to discover new classes of antimicrobial agents for treating multi-resistant infections Nosopharm, a company dedicated to the research and development …
The spectre of a dwindling supply of effective antibiotics is considered one of the gravest threats to public health – one that could soon claim …
Locus Biosciences has closed $19 million in Series A funding led by venture capital firm ARTIS Ventures with additional financing from notable institutional investors Tencent …
In 2017, the collective fight to combat antimicrobial resistance (AMR) has experienced a new upswing. Following the eye-opening report of British economist Lord Jim O’Neill, …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
